Which Institutions Own Shares In Elevance Health Inc (ELV)?

Elevance Health Inc (NYSE: ELV) is 6.49% higher on its value in year-to-date trading and has touched a low of $412.00 and a high of $502.14 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ELV stock was last observed hovering at around $497.79 in the last trading session, with the day’s gains setting it 4.36%.

Currently trading at $502.15, the stock is 4.10% and 5.02% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.91 million and changing 0.88% at the moment leaves the stock 8.99% off its SMA200. ELV registered 5.08% gain for a year compared to 6-month gain of 9.08%. The firm has a 50-day simple moving average (SMA 50) of $0.80.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a 3.91% loss in the last 1 month and extending the period to 3 months gives it a 9.82%, and is 1.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.48% over the week and 1.91% over the month.

Elevance Health Inc (ELV) has around 102300 employees, a market worth around $117.99B and $171.34B in sales. Current P/E ratio is 19.95 and Fwd P/E is 12.10. Profit margin for the company is 3.49%. Distance from 52-week low is 21.88% and 0.00% from its 52-week high. The company has generated returns on investments over the last 12 months (9.57%).

Elevance Health Inc quarterly earnings per share for the current quarter are estimated at $10.48 with sales reaching $42.27B over the same period.The EPS is expected to grow by 12.05% this year, but quarterly earnings will post 1.10% year-over-year. Quarterly sales are estimated to grow 3.50% in year-over-year returns.

2,139 institutions hold shares in Elevance Health Inc (ELV), with institutional investors hold 92.21% of the company’s shares. The shares outstanding are 237.96M, and float is at 233.98M with Short Float at 0.82%. Institutions hold 92.03% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 21.33 million shares valued at $9.48 billion. The investor’s holdings represent 9.08% of the ELV Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 20.39 million shares valued at $9.06 billion to account for 8.68% of the shares outstanding. The other top investors are Price (T.Rowe) Associates Inc which holds 12.1 million shares representing 5.15% and valued at over $5.38 billion, while State Street Corporation holds 4.67% of the shares totaling 10.98 million with a market value of $4.88 billion.

Elevance Health Inc (ELV) Insider Activity

A total of 5 insider transactions have happened at Elevance Health Inc (ELV) in the last six months, with sales accounting for 3 and purchases happening 2 times. The most recent transaction is an insider sale by Todt Blair Williams, the company’s EVP, CLO & CAO. SEC filings show that Todt Blair Williams sold 5,492 shares of the company’s common stock on Dec 14 at a price of $484.02 per share for a total of $2.66 million. Following the sale, the insider now owns 12512.0 shares.

Elevance Health Inc disclosed in a document filed with the SEC on Nov 30 that Penczek Ronald W (CAO & Controller) sold a total of 1,055 shares of the company’s common stock. The trade occurred on Nov 30 and was made at $475.17 per share for $0.5 million. Following the transaction, the insider now directly holds 1787.0 shares of the ELV stock.

Still, SEC filings show that on Oct 24, Penczek Ronald W (CAO & Controller) disposed off 64 shares at an average price of $454.35 for $29078.0. The insider now directly holds 2,842 shares of Elevance Health Inc (ELV).

Elevance Health Inc (ELV): Who are the competitors?

One of the company’s main competitors (and peers) include UnitedHealth Group Inc. (UNH) that is trading 5.23% up over the past 12 months.Cigna Group (CI) lies in the list of competitors of the Elevance Health Inc and is 12.07% higher over the same period from ELVHumana Inc. (HUM) is -26.24% down on the 1-year trading charts.